Detroit area physician admits providing medically unnecessary chemotherapy as part of $225M fraud scheme

Farid Fata, MD, a Detroit-area hematologist-oncologist, has pleaded guilty to participating in a healthcare fraud scheme and admitted to administering unnecessary chemotherapy to patients to enable him to fraudulently bill Medicare and private insurance companies for the treatment, according to the FBI.

Advertisement

Dr. Fata owned and operated Michigan Hematology Oncology, a cancer treatment clinic, which had locations in seven Michigan cities: Rochester Hills, Clarkston, Bloomfield Hills, Lapeer, Sterling Heights, Troy, and Oak Park. He also owned United Diagnostics in Rochester Hills.

In his guilty plea, Dr. Fata admitted he prescribed and administered aggressive chemotherapy, cancer treatments, intravenous iron and other infusion therapies to patients who did not need them to increase the amount he could bill Medicare and private insurance companies.

Dr. Fata also admitted to soliciting kickbacks from home healthcare companies in exchange for his referral of patients to those facilities.

Dr. Fata pleaded guilty to 13 counts of healthcare fraud, one count of conspiracy to pay or receive kickbacks and two counts of money laundering. Through the scheme, Dr. Fata submitted approximately $225 million in claims to Medicare from August 2007 to July 2013. 

More articles on healthcare industry lawsuits:

Gilead Sciences faces False Claims Act case alleging defective-drug fraud
7 recent healthcare industry lawsuits, settlements
EmblemHealth subsidiary to establish $3.5M fund for violating out of network disclosure requirements

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.